Provention Bio, Inc.
Provention Bio, Inc. (PRVB) Revenue
Annual & quarterly revenue history · segment & region breakdown
PRVB · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsProvention Bio, Inc. trailing twelve-month (TTM) revenue is $0.01B, an increase of 824.37% year-over-year from $0.01B in FY2022.
Revenue trend
2022 – 2017 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2022-12-31 | $0.01B | +$0.01B | +824.37% |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | +$0.00B | — |
| 2018-12-31 | $0.00B | +$0.00B | — |
| 2017-12-31 | $0.00B | — | — |
Compare revenue vs peers
BiotechnologyCompare PRVB revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Provention Bio, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Provention Bio, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Provention Bio, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PRVB revenue · 4 questionsPRVB's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 824.37% year-over-year from $0.01B in FY2022.
▸ Source: FMP · Provention Bio, Inc. SEC filings · GAAP · Provention Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026